溶瘤病毒免疫疗法
Oncolytic Virus Immunotherapy.
作者信息
Marchini Antonio, Ilkow Carolina S, Melcher Alan
机构信息
Laboratory of Oncolytic Virus Immuno-Therapeutics, Luxembourg Institute of Health, 84 Val Fleuri, L-1526 Luxembourg, Luxembourg.
German Cancer Research Centre, Laboratory of Oncolytic Virus Immuno-Therapeutics, Im Neuenheimer Feld 242, 69120 Heidelberg, Germany.
出版信息
Cancers (Basel). 2021 Jul 22;13(15):3672. doi: 10.3390/cancers13153672.
Abstract
Oncolytic viruses (OVs) were originally developed as direct cytotoxic agents but have been increasingly recognised as a form of immunotherapy [...].
摘要
溶瘤病毒（OVs）最初是作为直接细胞毒性剂开发的，但越来越被认为是一种免疫疗法[……]。
相似文献
1
Oncolytic Virus Immunotherapy.溶瘤病毒免疫疗法
Cancers (Basel). 2021 Jul 22;13(15):3672. doi: 10.3390/cancers13153672.
2
Design and application of oncolytic viruses for cancer immunotherapy.溶瘤病毒在癌症免疫治疗中的设计与应用。
Curr Opin Biotechnol. 2020 Oct;65:25-36. doi: 10.1016/j.copbio.2019.11.016. Epub 2019 Dec 23.
3
The limiting factors of oncolytic virus immunotherapy and the approaches to overcome them.溶瘤病毒免疫疗法的限制因素及克服这些因素的方法。
Appl Microbiol Biotechnol. 2020 Oct;104(19):8231-8242. doi: 10.1007/s00253-020-10802-w. Epub 2020 Aug 20.
4
Fighting Cancer with Viruses: Oncolytic Virus Therapy in China.用病毒对抗癌症：中国的溶瘤病毒治疗。
Hum Gene Ther. 2018 Feb;29(2):151-159. doi: 10.1089/hum.2017.212.
5
Updates to the antitumor mechanism of oncolytic virus.肿瘤溶瘤病毒抗肿瘤机制的研究进展。
Thorac Cancer. 2019 May;10(5):1031-1035. doi: 10.1111/1759-7714.13043. Epub 2019 Mar 22.
6
Double trouble for tumours: exploiting the tumour microenvironment to enhance anticancer effect of oncolytic viruses.肿瘤的双重困境：利用肿瘤微环境增强溶瘤病毒的抗癌效果。
Cytokine Growth Factor Rev. 2010 Apr-Jun;21(2-3):135-41. doi: 10.1016/j.cytogfr.2010.02.007. Epub 2010 Mar 24.
7
The viral approach to breast cancer immunotherapy.病毒方法在乳腺癌免疫治疗中的应用。
J Cell Physiol. 2019 Feb;234(2):1257-1267. doi: 10.1002/jcp.27150. Epub 2018 Aug 26.
8
Sharpening the Edge for Precision Cancer Immunotherapy: Targeting Tumor Antigens through Oncolytic Vaccines.磨砺精准癌症免疫疗法的利刃：通过溶瘤疫苗靶向肿瘤抗原
Front Immunol. 2017 Jul 13;8:800. doi: 10.3389/fimmu.2017.00800. eCollection 2017.
9
Genetic modification of oncolytic viruses to enhance antitumor immunity.对溶瘤病毒进行基因改造以增强抗肿瘤免疫力。
Methods Enzymol. 2020;635:231-250. doi: 10.1016/bs.mie.2019.05.017. Epub 2019 Jun 11.
10
Unleashing the therapeutic potential of oncolytic viruses.释放溶瘤病毒的治疗潜力。
J Clin Invest. 2018 Apr 2;128(4):1258-1260. doi: 10.1172/JCI120303. Epub 2018 Mar 5.
引用本文的文献
1
Oncolytic immunovirotherapy: finding the tumor antigen needle in the antiviral haystack.溶瘤免疫病毒疗法：在抗病毒的干草堆中寻找肿瘤抗原这根针。
Immunotherapy. 2025 Jun;17(8):585-594. doi: 10.1080/1750743X.2025.2513853. Epub 2025 Jun 6.
2
Biomarker screen for efficacy of oncolytic virotherapy in patient-derived pancreatic cancer cultures.用于患者来源的胰腺癌培养物中溶瘤病毒治疗疗效的生物标志物筛选。
EBioMedicine. 2024 Jul;105:105219. doi: 10.1016/j.ebiom.2024.105219. Epub 2024 Jun 27.
3
Engineering Rapalog-Inducible Genetic Switches Based on Split-T7 Polymerase to Regulate Oncolytic Virus-Driven Production of Tumour-Localized IL-12 for Anti-Cancer Immunotherapy.基于分裂T7聚合酶构建雷帕霉素诱导型基因开关以调控溶瘤病毒驱动的肿瘤局部白细胞介素-12产生用于抗癌免疫治疗
Pharmaceuticals (Basel). 2023 May 7;16(5):709. doi: 10.3390/ph16050709.
4
Oncolytic Adenoviruses: The Cold War against Cancer Finally Turns Hot.溶瘤腺病毒：对抗癌症的冷战终于升温。
Cancers (Basel). 2022 Sep 27;14(19):4701. doi: 10.3390/cancers14194701.
5
Cancer Immunotherapy and Delivery System: An Update.癌症免疫疗法与递送系统：最新进展
Pharmaceutics. 2022 Aug 4;14(8):1630. doi: 10.3390/pharmaceutics14081630.
本文引用的文献
1
Combining Oncolytic Viruses and Small Molecule Therapeutics: Mutual Benefits.溶瘤病毒与小分子疗法的联合应用：互利共赢。
Cancers (Basel). 2021 Jul 6;13(14):3386. doi: 10.3390/cancers13143386.
2
Parking CAR T Cells in Tumours: Oncolytic Viruses as Valets or Vandals?将嵌合抗原受体T细胞储存在肿瘤中：溶瘤病毒是代客泊车者还是破坏者？
Cancers (Basel). 2021 Mar 5;13(5):1106. doi: 10.3390/cancers13051106.
3
Expanding the Spectrum of Pancreatic Cancers Responsive to Vesicular Stomatitis Virus-Based Oncolytic Virotherapy: Challenges and Solutions.扩大对基于水疱性口炎病毒的溶瘤病毒疗法有反应的胰腺癌谱：挑战与解决方案
Cancers (Basel). 2021 Mar 9;13(5):1171. doi: 10.3390/cancers13051171.
4
Oncolytic Virotherapy: The Cancer Cell Side.溶瘤病毒疗法：癌细胞视角
Cancers (Basel). 2021 Feb 24;13(5):939. doi: 10.3390/cancers13050939.
5
Tackling HLA Deficiencies Head on with Oncolytic Viruses.用溶瘤病毒直接攻克HLA缺陷
Cancers (Basel). 2021 Feb 10;13(4):719. doi: 10.3390/cancers13040719.
6
Personalizing Oncolytic Virotherapy for Glioblastoma: In Search of Biomarkers for Response.胶质母细胞瘤溶瘤病毒疗法的个性化：寻找反应生物标志物
Cancers (Basel). 2021 Feb 4;13(4):614. doi: 10.3390/cancers13040614.
7
Oncolytic Virotherapy in Solid Tumors: The Challenges and Achievements.实体瘤中的溶瘤病毒疗法：挑战与成就
Cancers (Basel). 2021 Feb 3;13(4):588. doi: 10.3390/cancers13040588.
8
Measles Virus as an Oncolytic Immunotherapy.麻疹病毒作为一种溶瘤免疫疗法。
Cancers (Basel). 2021 Feb 1;13(3):544. doi: 10.3390/cancers13030544.
9
Parvovirus-Based Combinatorial Immunotherapy: A Reinforced Therapeutic Strategy against Poor-Prognosis Solid Cancers.基于细小病毒的联合免疫疗法：一种针对预后不良实体癌的强化治疗策略。
Cancers (Basel). 2021 Jan 19;13(2):342. doi: 10.3390/cancers13020342.
10
Immunotherapeutic Efficacy of Retargeted oHSVs Designed for Propagation in an Ad Hoc Cell Line.专为在特定细胞系中增殖而设计的重定向溶瘤单纯疱疹病毒的免疫治疗效果。
Cancers (Basel). 2021 Jan 12;13(2):266. doi: 10.3390/cancers13020266.
Zotero 插件